The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC)

被引:36
|
作者
Feliciano, David M. [1 ]
机构
[1] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA
来源
FRONTIERS IN NEUROANATOMY | 2020年 / 14卷
基金
美国国家卫生研究院;
关键词
TSC1; TSC2; mTOR; Tuber; SEGA; subependymal giant cell astrocytoma; FOCAL CORTICAL DYSPLASIA; GIANT-CELL ASTROCYTOMAS; AUTISTIC-LIKE BEHAVIOR; INDUCED RENAL TUMORS; EKER RAT MODEL; MOUSE MODEL; SOMATIC MUTATIONS; EPILEPSY SURGERY; MAMMALIAN TARGET; MTOR PATHWAY;
D O I
10.3389/fnana.2020.00039
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Tuberous sclerosis complex (TSC) is a model disorder for understanding brain development because the genes that cause TSC are known, many downstream molecular pathways have been identified, and the resulting perturbations of cellular events are established. TSC, therefore, provides an intellectual framework to understand the molecular and biochemical pathways that orchestrate normal brain development. The TSC1 and TSC2 genes encode Hamartin and Tuberin which form a GTPase activating protein (GAP) complex. Inactivating mutations in TSC genes (TSC1/TSC2) cause sustained Ras homologue enriched in brain (RHEB) activation of the mammalian isoform of the target of rapamycin complex 1 (mTORC1). TOR is a protein kinase that regulates cell size in many organisms throughout nature. mTORC1 inhibits catabolic processes including autophagy and activates anabolic processes including mRNA translation. mTORC1 regulation is achieved through two main upstream mechanisms. The first mechanism is regulation by growth factor signaling. The second mechanism is regulation by amino acids. Gene mutations that cause too much or too little mTORC1 activity lead to a spectrum of neuroanatomical changes ranging from altered brain size (micro and macrocephaly) to cortical malformations to Type I neoplasias. Because somatic mutations often underlie these changes, the timing, and location of mutation results in focal brain malformations. These mutations, therefore, provide gain-of-function and loss-of-function changes that are a powerful tool to assess the events that have gone awry during development and to determine their functional physiological consequences. Knowledge about the TSC-mTORC1 pathway has allowed scientists to predict which upstream and downstream mutations should cause commensurate neuroanatomical changes. Indeed, many of these predictions have now been clinically validated. A description of clinical imaging and histochemical findings is provided in relation to laboratory models of TSC that will allow the reader to appreciate how human pathology can provide an understanding of the fundamental mechanisms of development.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] A dermatological assessment of pediatric patients with tuberous sclerosis complex (TSC)
    Nunes, Beatriz Azevedo
    Romano, Ana Karolina Ferreira Goncalves
    Morgan, Mariana Aparecida Pasa
    Goncalves, Alice Andrade
    Cardozo, Lais Faria Masulk
    de Almeida, Luiz Gustavo Dufner
    Haddad, Luciana Amaral
    Crippa, Ana Chrystina de Souza
    Antoniuk, Sergio Antonio
    Abagge, Kerstin Taniguchi
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2024, 99 (05) : 662 - 669
  • [32] Psychosocial impact of genetic testing for tuberous sclerosis complex (TSC).
    Clark-Gay, B
    Tucker, AJ
    Assel, MA
    Johnston, DA
    Au, KS
    Northrup, H
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 375 - 375
  • [33] Aspects of tuberous sclerosis complex (TSC) protein function in the brain
    Ramesh, V
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 579 - 583
  • [34] Association of Tuberous sclerosis complex (TSC) and Insulinoma in a pediatric patient
    Tangari Saredo, Ana
    Flores, Adriana
    Giaccaglia, Silvia
    Parias, Rodrigo
    Jorro, Facundo
    Dadvison, Brenda
    Gonzalez, Javiera
    Bastianello, Maria
    Korman, Luciano
    Bielsky, Laila
    Sol, Bupo
    Marta Bujan, Maria
    Burdet, Sofia
    Sandra, Tilitzky
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 246 - 246
  • [35] Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice
    Cao, Jiumei
    Gong, Limin
    Guo, Dong-chuan
    Mietzsch, Ulrike
    Kuang, Shao-Qing
    Kwartler, Callie S.
    Safi, Hazim
    Estrera, Anthony
    Gambello, Michael J.
    Milewicz, Dianna M.
    HUMAN MOLECULAR GENETICS, 2010, 19 (10) : 1908 - 1920
  • [36] Tubers and Tumors Are CLIPped Together in Tuberous Sclerosis Complex Commentary Short Title: CLIP Cells in Tuberous Sclerosis Complex (TSC)
    Dang, Louis T.
    EPILEPSY CURRENTS, 2022, 22 (04) : 255 - 257
  • [37] TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex
    Muzykewicz, D. A.
    Sharma, A.
    Muse, V.
    Numis, A. L.
    Rajagopal, J.
    Thiele, E. A.
    JOURNAL OF MEDICAL GENETICS, 2009, 46 (07) : 465 - 468
  • [38] RENAL EVALUATION OF PAEDIATRIC PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX (TSC) IN A NATIONAL TSC MULTIDISCIPLINARY CLINIC
    Patterson, Jenny
    Joss, Shelagh
    Shaheen, Ihab
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1753 - 1753
  • [39] Epilepsy in tuberous sclerosis complex (TSC): A retrospective population based study
    Camposano, Susana E.
    Lyczkowski, David A.
    Rakowski, Sonja K.
    Thiele, Elizabeth A.
    EPILEPSIA, 2006, 47 : 2 - 2
  • [40] Perinatal adversities in tuberous sclerosis complex: determinants and neurodevelopmental outcomes
    Zhang, Alexa X. D.
    Liang, Holan
    McEwen, Fiona S.
    Tye, Charlotte
    Woodhouse, Emma
    Underwood, Lisa
    Shephard, Elizabeth
    Sheerin, Fintan
    Bolton, Patrick F.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2022, 64 (10): : 1237 - 1245